Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| 1 |
Thermo Fisher Scientific
TMO
|
+$954M |
| 2 |
Salesforce
CRM
|
+$683M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$620M |
| 4 |
HCA Healthcare
HCA
|
+$560M |
| 5 |
Netflix
NFLX
|
+$445M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$861M |
| 2 |
Incyte
INCY
|
+$755M |
| 3 |
NVIDIA
NVDA
|
+$655M |
| 4 |
Charles Schwab
SCHW
|
+$534M |
| 5 |
MetLife
MET
|
+$373M |
Sector Composition
| 1 | Financials | 19.84% |
| 2 | Technology | 15.57% |
| 3 | Industrials | 8.44% |
| 4 | Healthcare | 8.44% |
| 5 | Energy | 7.61% |